Arry Biopharma Soars 20% On Positive Phase 3 Melanoma Trial By: TalkMarkets December 17, 2015 at 05:10 AM EST Arry Biopharma soars 20% on positive phase 3 Melanoma trial. Read More >> Related Stocks: Array Technologies Inc